
Hiddo J.L
Articles
-
Sep 30, 2024 |
eprints.gla.ac.uk | John J.V |Carolyn S.P |Hiddo J.L
Butt, J. H. et al. (2024) Therapeutic effects of heart failure medical therapies on standardized kidney outcomes: Comprehensive individual participant-level analysis of 6 randomized clinical trials. Circulation, (doi: 10.1161/circulationaha.124.071110) (PMID:39217458) (Accepted for Publication)Text334738.pdf - Accepted Version Restricted to Repository staff only until 30 March 2025.
-
Apr 16, 2024 |
eprints.gla.ac.uk | Hiddo J.L
Fletcher, R. A. et al. (2024) Effects of sodium-glucose cotransporter 2 inhibitors on cause-specific cardiovascular death in patients with CKD. Clinical Journal of the American Society of Nephrology, (doi: 10.2215/cjn.0000000000000470) (PMID:38622766) (Early Online Publication)Full text not currently available from Enlighten. AbstractNo abstract available.
-
Apr 16, 2024 |
eprints.gla.ac.uk | Hiddo J.L
Fletcher, R. A. et al. (2024) Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clinical Journal of the American Society of Nephrology, (doi: 10.2215/cjn.0000000000000470) (Early Online Publication)Full text not currently available from Enlighten. AbstractNo abstract available.
-
Feb 23, 2024 |
eprints.gla.ac.uk | Hiddo J.L
Denicolò, S. et al. (2024) Non-adherence to antidiabetic and cardiovascular medication as assessed by LC-MS/MSin urine and its association with kidney and cardiovascular outcomes in type 2 diabetesmellitus.
-
Feb 15, 2024 |
eprints.gla.ac.uk | Hiddo J.L |John J.V |Anna Maria
Heerspink, H. J.L. et al. (2024) Dapagliflozin and blood pressure in patients with chronic kidney disease and albuminuria. American Heart Journal, (doi: 10.1016/j.ahj.2024.02.006) (PMID:38367893) (In Press)Text320656.pdf - Accepted Version Restricted to Repository staff only until 15 February 2025.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →